GLP-1 Drugs Like Ozempic Linked to 30% Lower Breast Cancer Risk in Major Study
A study of 110,000+ women found GLP-1 users had ~30% lower breast cancer risk, sparking plans for clinical trials.
20 articles
A study of 110,000+ women found GLP-1 users had ~30% lower breast cancer risk, sparking plans for clinical trials.
Australian biotech company creates targeted treatment that attacks malignant plasma cells while sparing healthy ones in multiple myeloma patients.
New DoriVac platform uses folded DNA structures to trigger strong immune responses while being easier to manufacture and store than mRNA vaccines.
Glycidol, a toxic compound formed during oil refining, damages DNA and may explain higher cancer rates in fried food consumers.
A protein called HOXD13 drives skin cancer growth and shields tumors from immune cells โ disabling it could unlock powerful new treatments.
New compound AP503 activates GPR133 receptor to rebuild bone density in mice, offering hope for millions with osteoporosis.
Breakthrough platform mimics natural virus environment, exposing how antibodies truly attack HIV and Ebola for smarter vaccine design.
McGill scientists boosted NK cell cancer-killing power using reversible drug treatment, targeting leukemia, glioblastoma, and triple-negative breast cancer.
Scientists discover D-cysteine selectively targets cancer cells by disrupting their energy production without harming normal cells.
New research reveals how tumors communicate with immune cells to avoid detection, potentially leading to better biomarkers and treatments.
Researchers found 260,000 cancer-specific RNAs that act as molecular fingerprints and can be detected through simple blood tests.
A newly discovered bacteriophage inside common gut bacteria appears strongly linked to colorectal cancer, potentially explaining a long-standing medical paradox.
New research suggests people eating organic foods most frequently have significantly lower cancer rates than conventional food consumers.
New research reveals how tumors reprogram neutrophils to produce CCL3, turning immune defenders into cancer allies.
Chinese researchers developed a breakthrough method to mass-produce powerful immune cells that hunt and destroy cancer tumors.
A newly identified molecule called SLAMF6 exhausts cancer-fighting T cells from within โ and blocking it may revive failed immunotherapies.
New poll reveals major knowledge gap about processed meat and colorectal cancer, but plant-based diets can cut risk by 22%.
Northwestern researchers dramatically boosted cancer vaccine effectiveness by simply repositioning one protein fragment on their nanovaccine.
Breakthrough antibodies completely prevent EBV infection in lab models, offering hope against virus linked to cancer and chronic disease.
Single injection of engineered virus kills glioblastoma cells and activates immune system, extending patient survival in clinical trial.